Area of research
Pulmonary and Respiratory Medicine · Pharmaceutical Science
Research interest
Research interests include Inhalation and Respiratory Drug Delivery, Advanced Drug Delivery Systems, Drug Solubulity and Delivery Systems, and Microencapsulation and Drying Processes.
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways
Nasal delivery as a strategy for the prevention and treatment of COVID-19
Dry Powder Inhalation Technology for Heart Targeting Applied to Calcium Phosphate Nanoparticles Loaded with Active Substances
Inhalable Microparticles Embedding Calcium Phosphate Nanoparticles for Heart Targeting: The Formulation Experimental Design
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats
Aerosolization Performance of Jet Nebulizers and Biopharmaceutical Aspects
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Dose administration maneuvers and patient care in tobramycin dry powder inhalation therapy
Opportunity and challenges of nasal powders: Drug formulation and delivery
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect
Overview on gastroretentive drug delivery systems for improving drug bioavailability
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery
Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats
Formulation Strategies for Antitubercular Drugs by Inhalation
Effect of Flow Rate on <i>In Vitro</i> Aerodynamic Performance of NEXThaler <sup>®</sup> in Comparison with Diskus <sup>®</sup> and Turbohaler <sup>®</sup> Dry Powder Inhalers
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation
“Pierce and inhale” design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations
High shear mixing of lactose and salmeterol xinafoate dry powder blends: Biopharmaceutic and aerodynamic performances
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake
Towards the bioequivalence of pressurised metered dose inhalers 1: Design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient